Email Updates

Search form

You are here

AIDS Vaccines

There is momentum and promise in the search for an AIDS vaccine.

An effective preventive AIDS vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available—and an AIDS vaccine would play a powerful role in ensuring the end to the AIDS epidemic. 

While effective vaccines remain years away, there are more reasons for hope than ever before. Researchers are expanding on the result of a 2009 trial that showed, for the first time, that a vaccine can reduce the risk of HIV infection. They’re also pursuing groundbreaking research with other novel vaccine strategies, including broadly neutralizing antibodies that target a wide range of HIV strains. At the same time, there is also exciting work in efforts to understand if and how to cure HIV in people who are already infected. The timeline for this work is long and uncertain. Here, too, advocacy is needed to sustain momentum.

Today’s momentum depends on sustained funding. Policy makers and funders around the world must have the courage to sustain vital AIDS vaccine research for years to come, and advocates must keep the pressure on them to maintain their commitments.

What We're Reading

Richard Jefferys summarizes and explains new research appearing in Nature on infusing human subjects with broadly neutralizing antibodies for therapeutic and preventive use.

April 10, 2015

Join us on Tuesday, April 21 at 11am EDT for New Frontiers in HIV Prevention, Treatment and Cure—An advocate’s webinar on passive immunization with a presentation from Dr. Sarah Schlesinger of Rockefeller University.

April 9, 2015
AVAC

Local public skepticism during the recent West African Ebola outbreak demonstrates the need for comprehensive grassroots community and media engagement in biomedical HIV prevention research.

March 13, 2015
NYTimes
Subscribe to RSS - AIDS Vaccines